Aligos Therapeutics Inc. buy BiotechBee
Start price
03.03.24
/
50%
€1.06
Target price
30.04.26
€3.00
Performance (%)
-26.60%
Price
23.04.24
€0.78
Summary
This prediction is currently active. The prediction for Aligos Therapeutics Inc. disappoints with a performance of -26.60%. This prediction currently runs until 30.04.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Aligos Therapeutics Inc. | - | - |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
According to BiotechBee what are the pros and cons of Aligos Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aligos Therapeutics Inc. diskutieren
Buy mit Kursziel 3,0